CD8A and breast cancer: The reduction of collagen expression by our AgNPs-G treatment would be beneficial in a clinical setting due to reports of Kuczek et al. (2019), who found that a high collagen density negatively impacts the abundance of CD8+ cells in tumor and impairs cytotoxic activity in breast cancer tumors.